Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001209191-22-050888

Chief Operating Officer returned 2,629 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HIGH SUSANNA GATTI Chief Operating Officer 2022-09-20 Returned to the company −2,629 $13.70 $36,017 68,786 D
Loading xslF345X03/doc4.xml…